Literature DB >> 11774035

Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation.

D Vordermark1, T Shibata, J M Brown.   

Abstract

The oxygen requirement for chromophore formation potentially limits the use of green fluorescent protein as a reporter under hypoxic conditions. In the light of this, the applicability of a hypoxia-responsive enhanced green fluorescent protein (EGFP)-based system to the measurement of tumor hypoxia was tested in human HT 1080 fibrosarcoma cells stably transfected with a destabilized EGFP vector containing the hypoxia-responsive 5HRE-hCMVmp promoter or, as a positive control, the strong constitutive CMV promoter. After various schedules of hypoxia and reoxygenation, EGFP fluorescence of live cells was assessed by flow cytometry, and protein levels were analyzed by Western blot. Fluorescence of CMV promoter positive control cells dropped to 38+/-5% of aerobic levels after 12 hours at <0.02% oxygen, but was unaffected by higher oxygen concentrations. Following 12 hours at <0.02% oxygen, cells transfected with the hypoxia-responsive vector exhibited maximum fluorescence after 4 hours of subsequent reoxygenation, reaching 68+/-2% of the levels in CMV promoter controls under aerobic conditions. With such reoxygenation, these cells exhibited a constant increase in fluorescence between 2% and <0.02% oxygen. EGFP chromophore formation is only affected by near-anoxic oxygen concentrations. The correlation of fluorescence and oxygen concentration is restored by a 4-hour reoxygenation period due to oxidation of pre-synthesized EGFP and a delayed increase in EGFP protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11774035      PMCID: PMC1506559          DOI: 10.1038/sj.neo.7900192

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  29 in total

1.  Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells.

Authors:  D E Richard; E Berra; J Pouyssegur
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

2.  Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX.

Authors:  H Ruan; J Wang; L Hu; C S Lin; K R Lamborn; D F Deen
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Authors:  M S Wiesener; P M Münchenhagen; I Berger; N V Morgan; J Roigas; A Schwiertz; J S Jürgensen; G Gruber; P H Maxwell; S A Löning; U Frei; E R Maher; H J Gröne; K U Eckardt
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 4.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

5.  Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.

Authors:  N Koshikawa; K Takenaga; M Tagawa; S Sakiyama
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

6.  A rapid-mixing comparison of the mechanisms of radiosensitization by oxygen and misonidazole in CHO cells.

Authors:  D W Whillans; J W Hunt
Journal:  Radiat Res       Date:  1982-04       Impact factor: 2.841

7.  Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals.

Authors:  P Schemmer; H D Connor; G E Arteel; J A Raleigh; H Bunzendahl; R P Mason; R G Thurman
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

8.  Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.

Authors:  Toru Shibata; Amato J Giaccia; J Martin Brown
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

9.  Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.

Authors:  K Haustermans; I Hofland; L Van de Pavert; K Geboes; M Varia; J Raleigh; A C Begg
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

10.  Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

Authors:  S M Evans; S Hahn; D R Pook; W T Jenkins; A A Chalian; P Zhang; C Stevens; R Weber; G Weinstein; I Benjamin; N Mirza; M Morgan; S Rubin; W G McKenna; E M Lord; C J Koch
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

View more
  38 in total

1.  Noninvasive real-time imaging of apoptosis.

Authors:  Bharathi Laxman; Daniel E Hall; Mahaveer Swaroop Bhojani; Daniel A Hamstra; Thomas L Chenevert; Brian D Ross; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

2.  The hypoxic tumor microenvironment in vivo selects tumor cells with increased survival against genotoxic stresses.

Authors:  Hoon Kim; Qun Lin; Zhong Yun
Journal:  Cancer Lett       Date:  2018-05-30       Impact factor: 8.679

3.  The focal adhesion protein kindlin-2 controls mitotic spindle assembly by inhibiting histone deacetylase 6 and maintaining α-tubulin acetylation.

Authors:  Hui-Foon Tan; Suet-Mien Tan
Journal:  J Biol Chem       Date:  2020-03-13       Impact factor: 5.157

4.  Detection of Low Oxygen Microenvironments in a Murine Model of Invasive Pulmonary Aspergillosis Using Pimonidazole.

Authors:  Nora Grahl; Caitlin H Kowalski; Robert A Cramer
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Molecular and functional imaging insights into the role of hypoxia in cancer aggression.

Authors:  Samata Kakkad; Balaji Krishnamachary; Desmond Jacob; Jesus Pacheco-Torres; Eibhlin Goggins; Santosh Kumar Bharti; Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

6.  Direct visualization of the phenotype of hypoxic tumor cells at single cell resolution in vivo using a new hypoxia probe.

Authors:  Yarong Wang; Haoxuan Wang; Jiufeng Li; David Entenberg; Alice Xue; Weigang Wang; John Condeelis
Journal:  Intravital       Date:  2016-05-16

7.  SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.

Authors:  Peter C Hart; Tatsuyuki Chiyoda; Xiaojing Liu; Melanie Weigert; Marion Curtis; Chun-Yi Chiang; Rachel Loth; Ricardo Lastra; Stephanie M McGregor; Jason W Locasale; Ernst Lengyel; Iris L Romero
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

8.  Tumor hypoxia imaging.

Authors:  Xilin Sun; Gang Niu; Nicholas Chan; Baozhong Shen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

Review 9.  'In vivo' optical approaches to angiogenesis imaging.

Authors:  T J A Snoeks; C W G M Löwik; E L Kaijzel
Journal:  Angiogenesis       Date:  2010-05-08       Impact factor: 9.596

10.  A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level.

Authors:  Raghu Erapaneedi; Vsevolod V Belousov; Michael Schäfers; Friedemann Kiefer
Journal:  EMBO J       Date:  2015-11-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.